Biochemical and body weight changes with metformin in polycystic ovary syndrome

Clinical and Experimental Obstetrics and Gynecology

Volumn 28, Issue 4, 2001, Pages 212-214

  Baysal, B ^a   Batukan, M ^a   Batukan, C ^a  

^a NONE   (Turkey)

Author keywords

Body mass index; Metformin; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; INSULIN; METFORMIN;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERINSULINISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LONG TERM CARE; MENSTRUAL CYCLE; OBESITY; OVARY POLYCYSTIC DISEASE; TREATMENT OUTCOME;

ADULT; BODY WEIGHT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MENSTRUATION; METFORMIN; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TESTOSTERONE;

EID: 0035710886     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
2. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double blind, placebocontrolled 6 month trial, followed by open, long term clinical evaluation
3. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
4. Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome
5. Menstrual cyclicity after metformin therapy in polycycstic ovary syndrome
6. Metformin therapy improves the menstruel pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
7. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
8. Insulin sensitizers and polycystic ovary syndrome: Can a diabetes medication treat infertility?
9. Inhibitory effect of sandostatin on secretion of luteinizing hormone and ovarian steroids in polycystic ovary syndrome
10. Insulin lowering medications in polycystic ovary syndrome
11. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian p450c17a activity and serum androgens
12. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
13. Metformin improves insulin, body fat distribution and androgens in obese women with and without the polycystic ovary syndrome
14. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome